We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
lnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has granted QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA), a leading provider of innovative enabling technologies and products for the separation, purification and handling of nucleic acids and proteins, a non-exclusive license to provide research products and services in RNA interference (RNAi) under the Kreutzer-Limmer patent family.
LAM Pharmaceutical, Corp. (OTC BB: LAMP -- News; Frankfurt: LAM -- News; Berlin: LAM -- News), a biomedical company focused on the development and commercialization of novel wound healing and transdermal drug delivery systems, announced today that Ministerio de Salud Republica Costa Rica, Direccion de Registros y Controles (Ministry of Health, Republic of Costa Rica, Directorate of Registrations and Controls) granted LAM Pharmaceutical a clearance to market and sell its patented and proprietary LAM IPM Wound Gel(TM) in Costa Rica, under the registration code DRC-19902.
OSI Pharmaceuticals, Inc. (NASDAQ:OSIP) announced today that its international partner for Tarceva(R) (erlotinib), Roche, received approval from the European Commission of Tarceva for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of at least one prior chemotherapy regimen.
Danish biopharmaceutical company Bavarian Nordic AS said the US International Trade Commission has started an investigation against Acambis PLC's MVA smallpox vaccine following a complaint of patent infringement by the Danish company.
Neurobiological Technologies Inc. (NTII.O: Quote, Profile, Research) on Tuesday said it agreed to sell worldwide rights in Xerecept, a phase III clinical compound for the treatment for swelling associated with brain tumors, to Celtic Pharma Holdings L.P. for $33 million.
Although South Africa has one of highest rates of spending on healthcare in the world, as a percentage of GDP, recent reports indicate that 60% of funding goes towards private healthcare, which is used by only 15% of the population.